Multi Center Ulcerative Colitis Pediatric Pentasa Intervention Trial (MUPPIT). A Randomized, Single-blinded, Controlled, Parallel, Induction Therapy With Once vs. Twice Daily Dosing of Pentasa in Pediatric UC

Trial Profile

Multi Center Ulcerative Colitis Pediatric Pentasa Intervention Trial (MUPPIT). A Randomized, Single-blinded, Controlled, Parallel, Induction Therapy With Once vs. Twice Daily Dosing of Pentasa in Pediatric UC

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Dec 2015

At a glance

  • Drugs Mesalazine (Primary)
  • Indications Ulcerative colitis
  • Focus Therapeutic Use
  • Acronyms MUPPIT
  • Most Recent Events

    • 07 Dec 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 10 Dec 2014 Planned End Date changed from 1 Mar 2013 to 1 Jun 2015, as reported by ClinicalTrials.gov.
    • 10 Dec 2014 Planned primary completion date changed from 1 Dec 2012 to 1 Mar 2015, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top